TAIM
PFE icon

Te Ahumairangi Investment Management’s Pfizer PFE Stock Holding History

Te Ahumairangi Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93M Buy
211,112
+323
+0.2% +$8.6K 0.99% 33
2025
Q4 		$5.25M Sell
210,789
-45,057
-18% -$1.14M 0.94% 32
2025
Q3 		$6.52M Buy
255,846
+6,800
+3% +$168K 1.11% 28
2025
Q2 		$6.04M Buy
249,046
+34,650
+16% +$808K 1.08% 29
2025
Q1 		$5.43M Buy
214,396
+14,973
+8% +$392K 1.15% 29
2024
Q4 		$5.29M Sell
199,423
-13,200
-6% -$358K 1.11% 28
2024
Q3 		$6.12M Buy
212,623
+11,000
+5% +$321K 1.08% 34
2024
Q2 		$5.64M Sell
201,623
-12,491
-6% -$344K 1.08% 36
2024
Q1 		$5.94M Buy
214,114
+14,190
+7% +$394K 1.03% 37
2023
Q4 		$5.76M Sell
199,924
-34,000
-15% -$1.03M 1.09% 36
2023
Q3 		$7.76M Buy
233,924
+6,780
+3% +$240K 1.26% 27
2023
Q2 		$8.33M Buy
227,144
+23,050
+11% +$897K 1.14% 34
2023
Q1 		$8.33M Buy
204,094
+34,975
+21% +$1.51M 1.19% 25
2022
Q4 		$8.67M Sell
169,119
-3,000
-2% -$144K 1.36% 24
2022
Q3 		$7.53M Sell
172,119
-3,485
-2% -$169K 1.28% 28
2022
Q2 		$9.21M Sell
175,604
-1,430
-0.8% -$72.9K 1.39% 24
2022
Q1 		$9.16M Buy
177,034
+14,205
+9% +$737K 1.24% 28
2021
Q4 		$9.62M Buy
162,829
+30,000
+23% +$1.49M 1.24% 29
2021
Q3 		$5.71M Buy
132,829
+11,000
+9% +$487K 0.79% 56
2021
Q2 		$4.77M Buy
121,829
+13,000
+12% +$506K 0.62% 70
2021
Q1 		$3.94M Buy
108,829
+57,000
+110% +$2.02M 0.51% 76
2020
Q4 		$1.91M Buy
51,829
+2,471
+5% +$90.6K 0.27% 97
2020
Q3 		$1.72M Buy
+49,358
New +$1.73M 0.29% 95

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Te Ahumairangi Investment Management's PFE Position: Q1 2026 in Review

Te Ahumairangi Investment Management increased its Pfizer (PFE) stake by 0.15% in Q1 2026, buying an estimated $8.6K and bringing the position to 211,112 shares worth $5.93M. The position accounts for 0.99% of the portfolio, ranked #33.

Te Ahumairangi Investment Management first reported a position in PFE in Q3 2020 and has held it in 23 quarters since. The position peaked at $9.62M in Q4 2021. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Te Ahumairangi Investment Management held 211,112 shares of Pfizer worth $5.93M as of Q1 2026.
  • Te Ahumairangi Investment Management bought 323 Pfizer shares in Q1 2026, an estimated $8.6K.
  • Pfizer made up 0.99% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #33 holding.
  • Te Ahumairangi Investment Management first reported a position in Pfizer in Q3 2020 and has held it in 23 quarters since.
  • Te Ahumairangi Investment Management's Pfizer position peaked at $9.62M in Q4 2021.
  • 2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.